Please login to the form below

Not currently logged in
Email:
Password:

talimogene laherparepvec

This page shows the latest talimogene laherparepvec news and features for those working in and with pharma, biotech and healthcare.

Rare disease therapies head the ‘class of 2015’

Rare disease therapies head the ‘class of 2015’

A product in a new class of cancer therapies that harness the cell-killing power of viruses also debuted in 2015 in the form of Amgen's Imlygic (talimogene laherparepvec), the ... Switzerland. talimogene laherparepvec. Imlygic. malignant melanoma.

Latest news

More from news
Approximately 4 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Helen Lawn and Associates

Established in 2000, Helen Lawn and Associates has gained widespread industry recognition as a trusted, UK-based healthcare PR agency. Our...

Latest intelligence

Legal developments in product liability
With restrictive legislation and recent landmark cases, the medical industry is under increasing legal pressure...
The role of empathy in the design of products and services
Peter Timmer of Blue Latitude Health talks through what it means to design with empathy for the customer, and why it produces better products and services....
Medius Deal Watch
Deal Watch April 2016
...

Infographics